Global Orally Disintegrating Tablet Market Survey and Trend Research 2018

June 2018 | 83 pages | ID: GCDA3E6D6E4EN
99Strategy

Abstracts

Summary

An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (Teva, Merck, Mylan, Pfizer, GSK, GSK, Otsuka, Eli Lilly and Company, AstraZeneca, Bristol-Myers Squibb, Conquer etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Orally Disintegrating Tablet Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 ORALLY DISINTEGRATING TABLET MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 Teva (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Merck (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Mylan (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Pfizer (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 GSK (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 GSK (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Otsuka (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Eli Lilly and Company (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 AstraZeneca (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 Bristol-Myers Squibb (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 Conquer (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

TABLE GLOBAL ORALLY DISINTEGRATING TABLET MARKET 2012-2017, BY TYPE, IN USD MILLION

Table Global Orally Disintegrating Tablet Market 2012-2017, by Type, in Volume
Table Global Orally Disintegrating Tablet Market Forecast 2018-2023, by Type, in USD Million
Table Global Orally Disintegrating Tablet Market Forecast 2018-2023, by Type, in Volume
Table Teva Overview List
Table Orally Disintegrating Tablet Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Overview List
Table Orally Disintegrating Tablet Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mylan Overview List
Table Orally Disintegrating Tablet Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Orally Disintegrating Tablet Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GSK Overview List
Table Orally Disintegrating Tablet Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GSK Overview List
Table Orally Disintegrating Tablet Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Otsuka Overview List
Table Orally Disintegrating Tablet Business Operation of Otsuka (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly and Company Overview List
Table Orally Disintegrating Tablet Business Operation of Eli Lilly and Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Overview List
Table Orally Disintegrating Tablet Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Overview List
Table Orally Disintegrating Tablet Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Conquer Overview List
Table Orally Disintegrating Tablet Business Operation of Conquer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Orally Disintegrating Tablet Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Orally Disintegrating Tablet Sales Revenue Share, by Companies, in USD Million
Table Global Orally Disintegrating Tablet Sales Volume 2012-2017, by Companies, in Volume
Table Global Orally Disintegrating Tablet Sales Revenue Share, by Companies in 2017, in Volume
Table Orally Disintegrating Tablet Demand 2012-2017, by Application, in USD Million
Table Orally Disintegrating Tablet Demand 2012-2017, by Application, in Volume
Table Orally Disintegrating Tablet Demand Forecast 2018-2023, by Application, in USD Million
Table Orally Disintegrating Tablet Demand Forecast 2018-2023, by Application, in Volume
Table Global Orally Disintegrating Tablet Market 2012-2017, by Region, in USD Million
Table Global Orally Disintegrating Tablet Market 2012-2017, by Region, in Volume
Table Orally Disintegrating Tablet Market Forecast 2018-2023, by Region, in USD Million
Table Orally Disintegrating Tablet Market Forecast 2018-2023, by Region, in Volume

List Of Figures

LIST OF FIGURES

Figure Orally Disintegrating Tablet Industry Chain Structure
Figure Global Orally Disintegrating Tablet Market Growth 2012-2017, by Type, in USD Million
Figure Global Orally Disintegrating Tablet Market Growth 2012-2017, by Type, in Volume
Figure Global Orally Disintegrating Tablet Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Orally Disintegrating Tablet Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region